1. Home
  2. QBTS vs KRYS Comparison

QBTS vs KRYS Comparison

Compare QBTS & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo D-Wave Quantum Inc.

QBTS

D-Wave Quantum Inc.

HOLD

Current Price

$24.27

Market Cap

9.7B

Sector

Technology

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$345.32

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QBTS
KRYS
Founded
1999
2015
Country
United States
United States
Employees
388
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
9.6B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
QBTS
KRYS
Price
$24.27
$345.32
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
11
Target Price
$32.53
$297.60
AVG Volume (30 Days)
39.7M
242.1K
Earning Date
05-12-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
128.00
EPS
N/A
1.83
Revenue
N/A
$389,130,000.00
Revenue This Year
$81.05
$38.74
Revenue Next Year
$93.13
$32.53
P/E Ratio
N/A
$186.02
Revenue Growth
N/A
33.94
52 Week Low
$12.75
$130.17
52 Week High
$46.75
$347.67

Technical Indicators

Market Signals
Indicator
QBTS
KRYS
Relative Strength Index (RSI) 49.74 73.08
Support Level $23.20 $253.89
Resistance Level $24.78 N/A
Average True Range (ATR) 2.40 12.58
MACD -0.54 3.13
Stochastic Oscillator 20.00 86.78

Price Performance

Historical Comparison
QBTS
KRYS

About QBTS D-Wave Quantum Inc.

D-Wave Quantum Inc is in the development and delivery of quantum computing systems, software, and services, and it is the commercial supplier of quantum computers and the only company building both annealing quantum computers and gate-model quantum computers. It delivers customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. Its annealing quantum computers are accessible through the company's LeapTM cloud service.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.

Share on Social Networks: